MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1α expression

Ling-Zhi Liu1, Chongyong Li, Qi Chen

  • 1Lab of Reproductive Medicine, Department of Pathology, Cancer Center, Nanjing Medical University, Nanjing, Jiangsu, China.

Plos One
|May 6, 2011
PubMed

Insights

MicroRNAs (miRNAs) like miR-21 promote tumor angiogenesis by activating AKT and ERK pathways, leading to increased HIF-1α and VEGF. Inhibiting miR-21 or its downstream targets blocks this tumor growth process.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) are key regulators of cellular functions and implicated in tumor development.
  • miR-21 is recognized for its role in tumor growth and metastasis.
  • The precise mechanism of miR-21 in regulating tumor angiogenesis requires further investigation.

Purpose of the Study:

  • To elucidate the role and molecular mechanism of miR-21 in regulating tumor angiogenesis.
  • To investigate the signaling pathways involved in miR-21-mediated angiogenesis.

Main Methods:

  • Overexpression of miR-21 in human prostate cancer cells (DU145) using pre-miR-21 transfection.
  • Assay of tumor angiogenesis using the chicken chorioallantoic membrane (CAM) model.
  • Analysis of signaling pathways including AKT, ERK, HIF-1α, and VEGF, and assessment of PTEN as a miR-21 target.

Main Results:

  • Overexpression of miR-21 induced tumor angiogenesis, increasing HIF-1α and VEGF expression.
  • miR-21 activated AKT and extracellular regulated kinases (ERK) 1/2 signaling pathways.
  • Inhibition of miR-21 or overexpression of its target PTEN blocked angiogenesis.
  • HIF-1α was identified as a critical downstream mediator of miR-21-induced angiogenesis.

Conclusions:

  • miR-21 promotes tumor angiogenesis by targeting PTEN, activating AKT and ERK1/2 signaling.
  • This activation enhances HIF-1α and VEGF expression, crucial for angiogenesis.
  • HIF-1α is essential for miR-21-mediated tumor angiogenesis, highlighting a key regulatory mechanism.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...